In last trading session, Prestige Consumer Healthcare Inc (NYSE:PBH) saw 0.86 million shares changing hands with its beta currently measuring 0.44. Company’s recent per share price level of $80.9 trading at -$0.25 or -0.31% at ring of the bell on the day assigns it a market valuation of $4.00B. That closing price of PBH’s stock is at a discount of -11.3% from its 52-week high price of $90.04 and is indicating a premium of 19.73% from its 52-week low price of $64.94. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.39 million shares which gives us an average trading volume of 370.45K if we extend that period to 3-months.
For Prestige Consumer Healthcare Inc (PBH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.17. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Prestige Consumer Healthcare Inc (NYSE:PBH) trade information
Upright in the red during last session for losing -0.31%, in the last five days PBH remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $80.9 price level, adding 5.15% to its value on the day. Prestige Consumer Healthcare Inc’s shares saw a change of 17.08% in year-to-date performance and have moved -3.04% in past 5-day. Prestige Consumer Healthcare Inc (NYSE:PBH) showed a performance of -4.09% in past 30-days. Number of shares sold short was 1.66 million shares which calculate 5.18 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 89.5 to the stock, which implies a rise of 9.61% to its current value. Analysts have been projecting 86 as a low price target for the stock while placing it at a high target of 93. It follows that stock’s current price would drop -6.3% in reaching the projected high whereas dropping to the targeted low would mean a loss of -6.3% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 9.02% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 5.51% while estimates for its earnings growth in next 5 years are of 4.72%.
Prestige Consumer Healthcare Inc (NYSE:PBH)’s Major holders
Insiders are in possession of 1.43% of company’s total shares while institution are holding 107.23 percent of that, with stock having share float percentage of 108.78%. Investors also watch the number of corporate investors in a company very closely, which is 107.23% institutions for Prestige Consumer Healthcare Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at PBH for having 8.28 million shares of worth $569.77 million. And as of 2024-06-30, it was holding 16.589 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 5.7 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.4233 of outstanding shares, having a total worth of $392.35 million.
